Clinical hold lifted for diabetes program, CFO appointed, increased cash position, R&D expenses noted
From GlobeNewswire: 2025-03-20 17:35:31 Clinical hold has been lifted for vTv Therapeutics’ cadisegliatin program for diabetes, allowing the Phase 3